primaquine has been researched along with Deficiency Diseases in 3 studies
Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.
Deficiency Diseases: A condition produced by dietary or metabolic deficiency. The term includes all diseases caused by an insufficient supply of essential nutrients, i.e., protein (or amino acids), vitamins, and minerals. It also includes an inadequacy of calories. (From Dorland, 27th ed; Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BOWDLER, AJ | 1 |
| PRANKERD, TA | 1 |
| Waller, HD | 1 |
| Löhr, GW | 1 |
| Gaetani, GF | 1 |
| Garré, C | 1 |
| Ajmar, F | 1 |
| Bianchi, GL | 1 |
3 other studies available for primaquine and Deficiency Diseases
| Article | Year |
|---|---|
STUDIES IN CONGENITAL NON-SPHEROCYTIC HAEMOLYTIC ANAEMIAS WITH SPECIFIC ENZYME DEFECTS.
Topics: Anemia, Hemolytic; Anemia, Hemolytic, Congenital Nonspherocytic; Carbohydrate Metabolism; Chromium I | 1964 |
[Hemolytic anemias. Enzymopenic hemolytic anemias].
Topics: Adenosine Triphosphatases; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Child; Deficiency Disea | 1966 |
Influence of riboflavin and of erythrocyte stroma on glutathione reductase activity in normal, glucose 6 phosphate dehydrogenase deficient and low glutathione reductase individuals.
Topics: Cell Membrane; Clinical Enzyme Tests; Deficiency Diseases; Drug Interactions; Enzyme Activation; Ery | 1973 |